Source: Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Robert A. Lewis, Charlotte Durrington, Robin Condliffe, David G. Kiely. BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?. Eur Respir Rev, 29 (156) 200009; 10.1183/16000617.0009-2020

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014 Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018 Year: 2018 Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer? Source: Eur Respir J 2009; 33: 1247-1249 Year: 2009 Early detection and management of pulmonary arterial hypertension Source: Eur Respir Rev 2012 21: 306-312 Year: 2012 Cardiopulmonary exercise testing for detection of early pulmonary vascular changes in relatives of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007 Pulmonary haemodynamics during exercise in patients with pulmonary arterial hypertension Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension Year: 2005 Use of a telemedicine application for training and follow up of patients with pulmonary arterial hypertension Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension Source: Eur Respir J 2012; 40: 1410-1419 Year: 2012 Heritable pulmonary hypertension: from bench to bedside Source: Eur Respir Rev, 26 (145) 170037; 10.1183/16000617.0037-2017 Year: 2017 Challenges in the diagnosis and treatment of pulmonary arterial hypertension Source: Eur Respir Rev 2012 21: 313-320 Year: 2012 Different work load protocols for cardiopulmonary exercize testing in patients with severe pulmonary arterial hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Right heart catheterisation is still a fundamental part of the follow-up assessment of pulmonary arterial hypertension Source: Eur Respir J, 52 (1) 1800738; 10.1183/13993003.00738-2018 Year: 2018 The imPAHct of diagnosis delay in pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Symptom-related telephone monitoring and cardiopulmonary exercise testing in the pulmonary embolism follow-up for early detection of chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed Source: Eur Respir J 2010; 36: 986-990 Year: 2010 Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease Source: Eur Respir Rev 2011; 20: 236-242 Year: 2011 The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 48s Year: 2006 Pulmonary arterial hypertension: tailoring treatment to risk in the current era Source: Eur Respir Rev, 26 (146) 170095; 10.1183/16000617.0095-2017 Year: 2017